Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Ductal carcinoma in situ and intraoperative partial breast irradiation: Who are the best candidates? Long-term outcome of a single institution series.

Leonardi MC, Corrao G, Frassoni S, Vingiani A, Dicuonzo S, Lazzeroni M, Fodor C, Morra A, Gerardi MA, Rojas DP, Dell'Acqua V, Marvaso G, Bassi FD, Galimberti VE, Veronesi P, Miglietta E, Cattani F, Zurrida S, Bagnardi V, Viale G, Orecchia R, Jereczek-Fossa BA.

Radiother Oncol. 2019 Apr;133:68-76. doi: 10.1016/j.radonc.2018.12.030. Epub 2019 Jan 17.

PMID:
30935584
2.

Could radiotherapy play a major role in misidentification of sentinel lymph node in breast cancer recurrence?

Lissidini G, Trifirò G, Veronesi P, Grana C, Zurrida S, Galimberti V, Corso G, Vellani C, Ivaldi GB.

Radiother Oncol. 2019 Feb;131:237-238. doi: 10.1016/j.radonc.2018.08.001. Epub 2018 Aug 30.

PMID:
30174108
3.

Robotic Nipple-sparing Mastectomy and Immediate Breast Reconstruction With Implant: First Report of Surgical Technique.

Toesca A, Peradze N, Galimberti V, Manconi A, Intra M, Gentilini O, Sances D, Negri D, Veronesi G, Rietjens M, Zurrida S, Luini A, Veronesi U, Veronesi P.

Ann Surg. 2017 Aug;266(2):e28-e30. doi: 10.1097/SLA.0000000000001397. No abstract available.

PMID:
28692558
4.

The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast.

Pruneri G, Lazzeroni M, Bagnardi V, Tiburzio GB, Rotmensz N, DeCensi A, Guerrieri-Gonzaga A, Vingiani A, Curigliano G, Zurrida S, Bassi F, Salgado R, Van den Eynden G, Loi S, Denkert C, Bonanni B, Viale G.

Ann Oncol. 2017 Feb 1;28(2):321-328. doi: 10.1093/annonc/mdw623.

PMID:
28426105
5.

Serum HER2 extracellular domain levels and HER2 circulating tumor cell status in patients with metastatic breast cancer.

Aurilio G, Sandri MT, Pruneri G, Zorzino L, Botteri E, Munzone E, Adamoli L, Facchi G, Cullurà D, Verri E, Rocca MC, Zurrida S, Iacovelli R, Nolè F.

Future Oncol. 2016 Sep;12(17):2001-8. doi: 10.2217/fon-2016-0081. Epub 2016 Jun 3.

PMID:
27255717
6.

New frontiers in proton therapy: applications in breast cancer.

Orecchia R, Fossati P, Zurrida S, Krengli M.

Curr Opin Oncol. 2015 Nov;27(6):427-32. doi: 10.1097/CCO.0000000000000228. Review.

PMID:
26371777
7.

Milestones in breast cancer treatment.

Zurrida S, Veronesi U.

Breast J. 2015 Jan-Feb;21(1):3-12. doi: 10.1111/tbj.12361. Epub 2014 Dec 15.

PMID:
25494903
8.

Oncoplastic technique in breast conservative surgery for locally advanced breast cancer.

Chirappapha P, Kongdan Y, Vassanasiri W, Ratchaworapong K, Sukarayothin T, Supsamutchai C, Klaiklern P, Leesombatpaiboon M, Hamza A, Zurrida S.

Gland Surg. 2014 Feb;3(1):22-7. doi: 10.3978/j.issn.2227-684X.2014.01.01. Review.

9.

Are all patients with ductal carcinoma in situ of the breast candidates for radiotherapy after breast conservative treatment? Institute of European Oncology Guidelines.

Farante G, Orecchia R, Luini A, Leonardi C, Zurrida S, Lissidini G, Krakobsky V, Veronesi U.

Breast J. 2014 Jul-Aug;20(4):431-3. doi: 10.1111/tbj.12295. Epub 2014 Jun 2. No abstract available.

PMID:
24888456
10.

Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial.

Veronesi U, Orecchia R, Maisonneuve P, Viale G, Rotmensz N, Sangalli C, Luini A, Veronesi P, Galimberti V, Zurrida S, Leonardi MC, Lazzari R, Cattani F, Gentilini O, Intra M, Caldarella P, Ballardini B.

Lancet Oncol. 2013 Dec;14(13):1269-77. doi: 10.1016/S1470-2045(13)70497-2. Epub 2013 Nov 11.

PMID:
24225155
11.

Breast phyllodes tumor: a review of literature and a single center retrospective series analysis.

Spitaleri G, Toesca A, Botteri E, Bottiglieri L, Rotmensz N, Boselli S, Sangalli C, Catania C, Toffalorio F, Noberasco C, Delmonte A, Luini A, Veronesi P, Colleoni M, Viale G, Zurrida S, Goldhirsch A, Veronesi U, De Pas T.

Crit Rev Oncol Hematol. 2013 Nov;88(2):427-36. doi: 10.1016/j.critrevonc.2013.06.005. Epub 2013 Jul 17. Review.

12.

High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapy.

Zurrida S, Bagnardi V, Curigliano G, Mastropasqua MG, Orecchia R, Disalvatore D, Greco M, Cataliotti L, D'Aiuto G, Talakhadze N, Goldhirsch A, Viale G.

Eur J Cancer. 2013 Oct;49(15):3083-92. doi: 10.1016/j.ejca.2013.05.007. Epub 2013 Jun 15.

PMID:
23777741
13.

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.

Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, Baratella P, Chifu C, Sargenti M, Intra M, Gentilini O, Mastropasqua MG, Mazzarol G, Massarut S, Garbay JR, Zgajnar J, Galatius H, Recalcati A, Littlejohn D, Bamert M, Colleoni M, Price KN, Regan MM, Goldhirsch A, Coates AS, Gelber RD, Veronesi U; International Breast Cancer Study Group Trial 23-01 investigators.

Lancet Oncol. 2013 Apr;14(4):297-305. doi: 10.1016/S1470-2045(13)70035-4. Epub 2013 Mar 11. Erratum in: Lancet Oncol. 2013 Jun;14(7):e254.

14.

Second malignancies following breast cancer treatment: a case-control study based on the Peridose methodology. Allegro project (task 5.4).

Orecchia R, Jereczek-Fossa BA, Rondi E, Bossi-Zanetti I, Meaglia I, Luraschi R, Leonardi MC, Rotmensz N, Botteri E, Fodor C, Cecconi A, Morra A, Lazzari R, Ferrari A, Cattani F, Galimberti V, Luini A, Veronesi P, Zurrida S, Magrini S, Doerr W, Humble N, Trott KR, Ottolenghi A, Smyth V, Veronesi U.

Tumori. 2012 Nov;98(6):715-21. doi: 10.1700/1217.13494. Erratum in: Tumori. 2013 May-Jun;99(3):e140.

PMID:
23389357
15.

Electronic portal imaging registration in breast cancer radiotherapy verification: analysis of inter-observer agreement among different categories of health practitioners.

Jereczek-Fossa BA, Santoro L, Colangione SP, Morselli L, Fodor C, Vischioni B, Rozza D, Leppa A, Cambria R, Leonardi MC, Morra A, Baroni G, Zurrida S, Orecchia R.

Neoplasma. 2013;60(3):302-8. doi: 10.4149/neo_2013_040.

PMID:
23374000
16.

Sentinel lymph node biopsy under local anesthesia in patients with breast cancer.

Chirappapha P, Lohsiriwat V, Kongdan Y, Lertsithichai P, Sukarayothin T, Supsamutchai C, Talakhadze N, Zurrida S.

Gland Surg. 2012 Nov;1(3):151-5. doi: 10.3978/j.issn.2227-684X.2012.10.09. Review. No abstract available.

17.

The Changing Face of Mastectomy (from Mutilation to Aid to Breast Reconstruction).

Zurrida S, Bassi F, Arnone P, Martella S, Del Castillo A, Ribeiro Martini R, Semenkiw ME, Caldarella P.

Int J Surg Oncol. 2011;2011:980158. doi: 10.1155/2011/980158. Epub 2011 Jun 5.

18.

Accelerated partial breast irradiation in early breast cancer: focus on intraoperative treatment with electrons (ELIOT).

Zurrida S, Leonardi MC, Del Castillo A, Lazzari R, Arnone P, Caldarella P.

Womens Health (Lond). 2012 Jan;8(1):89-98. doi: 10.2217/whe.11.86. Review.

19.

Local therapy for breast cancer in malignant lymphoma survivors.

Intra M, Mattar D, Sangalli C, Rotmensz N, Viale G, Galimberti V, Luini A, Veronesi P, Colleoni M, Zurrida S, Orecchia R, Veronesi U.

Breast. 2011 Oct;20 Suppl 3:S99-103. doi: 10.1016/S0960-9776(11)70304-6.

PMID:
22015303
20.

Breast cancer subtypes and outcome after local and regional relapse.

Montagna E, Bagnardi V, Rotmensz N, Viale G, Renne G, Cancello G, Balduzzi A, Scarano E, Veronesi P, Luini A, Zurrida S, Monti S, Mastropasqua MG, Bottiglieri L, Goldhirsch A, Colleoni M.

Ann Oncol. 2012 Feb;23(2):324-31. doi: 10.1093/annonc/mdr129. Epub 2011 Apr 27.

21.

Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer?

Galimberti V, Botteri E, Chifu C, Gentilini O, Luini A, Intra M, Baratella P, Sargenti M, Zurrida S, Veronesi P, Rotmensz N, Viale G, Sonzogni A, Colleoni M, Veronesi U.

Breast Cancer Res Treat. 2012 Feb;131(3):819-25. doi: 10.1007/s10549-011-1486-2. Epub 2011 Apr 6.

PMID:
21468637
22.

Receptor status (ER, PgR and HER2) discordance between primary tumor and locoregional recurrence in breast cancer.

Zurrida S, Montagna E, Naninato P, Colleoni M, Goldhirsch A.

Ann Oncol. 2011 Feb;22(2):479-80. doi: 10.1093/annonc/mdq688. No abstract available.

23.

Influence of margin status on outcomes in lobular carcinoma: experience of the European Institute of Oncology.

Galimberti V, Maisonneuve P, Rotmensz N, Viale G, Sangalli C, Sargenti M, Brenelli F, Gentilini O, Intra M, Bassi F, Luini A, Zurrida S, Veronesi P, Colleoni M, Veronesi U.

Ann Surg. 2011 Mar;253(3):580-4. doi: 10.1097/SLA.0b013e31820d9a81.

PMID:
21248632
24.

A new TNM classification for breast cancer to meet the demands of the present and the challenges of the future.

Zurrida S, Veronesi U.

Womens Health (Lond). 2011 Jan;7(1):41-9. doi: 10.2217/whe.10.82.

PMID:
21175390
25.

Nonpalpable breast carcinomas: long-term evaluation of 1,258 cases.

Veronesi U, Luini A, Botteri E, Zurrida S, Monti S, Galimberti V, Cassano E, Latronico A, Pizzamiglio M, Viale G, Vezzoli D, Rotmensz N, Musmeci S, Bassi F, Burgoa L, Maisonneuve P, Paganelli G, Veronesi P.

Oncologist. 2010;15(12):1248-52. doi: 10.1634/theoncologist.2010-0123. Epub 2010 Dec 8.

26.

A psychosocial cancer phone center staffed by professional psychologists as an integral part of the standard process of care: Its utility during the course of illness.

Arnaboldi P, Lupo FN, Santoro L, Rubio L, Tenore A, Solinas I, Delle Grotti F, Ferri V, Teresi N, Zurrida S, Didier F.

Palliat Support Care. 2010 Sep;8(3):305-12. doi: 10.1017/S1478951510000106.

PMID:
20875174
27.

The TNM classification of breast cancer: need for change.

Arnone P, Zurrida S, Viale G, Dellapasqua S, Montagna E, Arnaboldi P, Intra M, Veronesi U.

Updates Surg. 2010 Oct;62(2):75-81. doi: 10.1007/s13304-010-0014-y. No abstract available.

PMID:
20845013
28.

The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy.

Farante G, Zurrida S, Galimberti V, Veronesi P, Curigliano G, Luini A, Goldhirsch A, Veronesi U.

Breast Cancer Res Treat. 2011 Jul;128(2):369-78. doi: 10.1007/s10549-010-1124-4. Epub 2010 Aug 26. Erratum in: Breast Cancer Res Treat. 2011 Jul;128(2):379. Dosage error in article text.

PMID:
20740312
29.

Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons.

Veronesi U, Orecchia R, Luini A, Galimberti V, Zurrida S, Intra M, Veronesi P, Arnone P, Leonardi MC, Ciocca M, Lazzari R, Caldarella P, Rotmensz N, Sangalli C, Sances D, Maisonneuve P.

Breast Cancer Res Treat. 2010 Nov;124(1):141-51. doi: 10.1007/s10549-010-1115-5. Epub 2010 Aug 15.

PMID:
20711810
30.

Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features.

Montagna E, Bagnardi V, Rotmensz N, Viale G, Pruneri G, Veronesi P, Cancello G, Balduzzi A, Dellapasqua S, Cardillo A, Luini A, Zurrida S, Gentilini O, Mastropasqua MG, Bottiglieri L, Iorfida M, Goldhirsch A, Colleoni M.

Breast Cancer Res Treat. 2010 Dec;124(3):689-99. doi: 10.1007/s10549-010-1027-4. Epub 2010 Jul 13.

PMID:
20625816
31.

Male breast cancer.

Zurrida S, Nolè F, Bonanni B, Mastropasqua MG, Arnone P, Gentilini O, Latronico A.

Future Oncol. 2010 Jun;6(6):985-91. doi: 10.2217/fon.10.55. Review.

PMID:
20528235
32.

Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study.

Veronesi U, Viale G, Paganelli G, Zurrida S, Luini A, Galimberti V, Veronesi P, Intra M, Maisonneuve P, Zucca F, Gatti G, Mazzarol G, De Cicco C, Vezzoli D.

Ann Surg. 2010 Apr;251(4):595-600. doi: 10.1097/SLA.0b013e3181c0e92a.

PMID:
20195151
33.

No more axillary dissection in patients with ductal intraepithelial neoplasia (DIN).

Farante G, Galimberti V, Zurrida S, Veronesi P, Luini A, Veronesi U.

Eur J Cancer. 2010 Feb;46(3):476-8. doi: 10.1016/j.ejca.2009.12.004. Epub 2010 Jan 22.

PMID:
20097064
34.

Clinical relevance of HER2 overexpression/amplification in patients with small tumor size and node-negative breast cancer.

Curigliano G, Viale G, Bagnardi V, Fumagalli L, Locatelli M, Rotmensz N, Ghisini R, Colleoni M, Munzone E, Veronesi P, Zurrida S, Nolè F, Goldhirsch A.

J Clin Oncol. 2009 Dec 1;27(34):5693-9. doi: 10.1200/JCO.2009.22.0962. Epub 2009 Nov 2.

PMID:
19884553
35.

Intraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with (90)Y-labeled biotin.

Paganelli G, De Cicco C, Ferrari ME, Carbone G, Pagani G, Leonardi MC, Cremonesi M, Ferrari A, Pacifici M, Di Dia A, De Santis R, Galimberti V, Luini A, Orecchia R, Zurrida S, Veronesi U.

Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):203-11. doi: 10.1007/s00259-009-1260-4. Epub 2009 Sep 4.

PMID:
19760414
36.

Rethinking TNM: a breast cancer classification to guide to treatment and facilitate research.

Veronesi U, Zurrida S, Viale G, Galimberti V, Arnone P, Nolè F.

Breast J. 2009 May-Jun;15(3):291-5. doi: 10.1111/j.1524-4741.2009.00719.x.

PMID:
19645785
37.

Preserving life and conserving the breast.

Veronesi U, Zurrida S.

Lancet Oncol. 2009 Jul;10(7):736. doi: 10.1016/S1470-2045(09)70117-2. No abstract available.

38.

Awareness is the key to conquering male breast cancer.

Gentilini O, Zurrida S.

South Med J. 2009 Jul;102(7):677. doi: 10.1097/SMJ.0b013e3181a93bc0. No abstract available.

PMID:
19487998
39.

Breast cancer classification: time for a change.

Veronesi U, Zurrida S, Goldhirsch A, Rotmensz N, Viale G.

J Clin Oncol. 2009 May 20;27(15):2427-8. doi: 10.1200/JCO.2008.21.2647. Epub 2009 Apr 20. No abstract available.

PMID:
19380438
40.

Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases.

Veronesi U, Galimberti V, Paganelli G, Maisonneuve P, Viale G, Orecchia R, Luini A, Intra M, Veronesi P, Caldarella P, Renne G, Rotmensz N, Sangalli C, De Brito Lima L, Tullii M, Zurrida S.

Eur J Cancer. 2009 May;45(8):1381-8. doi: 10.1016/j.ejca.2008.11.041. Epub 2009 Jan 6.

PMID:
19128957
41.

Conservative treatments in breast cancer: an update from the European Institute of Oncology.

Zurrida S.

Womens Health (Lond). 2008 Jul;4(4):413-20. doi: 10.2217/17455057.4.4.413. Review.

PMID:
19072505
42.

Metamorphosis of melanoma. Trends in size and thickness of cutaneous melanoma over one decade at the Istituto Nazionale Tumori, Milan.

Bono A, Tolomio E, Bartoli C, Carbone A, Tomatis S, Zurrida S, Santinami M.

Tumori. 2008 Jan-Feb;94(1):11-3.

PMID:
18468328
43.

The surgical margin status after breast-conserving surgery: discussion of an open issue.

Luini A, Rososchansky J, Gatti G, Zurrida S, Caldarella P, Viale G, Rosali dos Santos G, Frasson A.

Breast Cancer Res Treat. 2009 Jan;113(2):397-402. doi: 10.1007/s10549-008-9929-0. Review.

PMID:
18386174
44.

Elderly breast cancer patients treated by conservative surgery alone plus adjuvant tamoxifen: fifteen-year results of a prospective study.

Martelli G, Miceli R, Costa A, Coradini D, Zurrida S, Piromalli D, Vetrella G, Greco M.

Cancer. 2008 Feb 1;112(3):481-8.

45.

Sentinel lymph node biopsy in male patients with early breast cancer.

Gentilini O, Chagas E, Zurrida S, Intra M, De Cicco C, Gatti G, Silva L, Renne G, Cassano E, Veronesi U.

Oncologist. 2007 May;12(5):512-5.

46.

The evolution of the conservative approach to breast cancer.

Luini A, Gatti G, Zurrida S, Talakhadze N, Brenelli F, Gilardi D, Paganelli G, Orecchia R, Cassano E, Viale G, Sangalli C, Ballardini B, dos Santos GR, Veronesi U.

Breast. 2007 Apr;16(2):120-9. Review.

PMID:
17403449
47.

Long-term oncological results of breast conservative treatment with oncoplastic surgery.

Rietjens M, Urban CA, Rey PC, Mazzarol G, Maisonneuve P, Garusi C, Intra M, Yamaguchi S, Kaur N, De Lorenzi F, Matthes AG, Zurrida S, Petit JY.

Breast. 2007 Aug;16(4):387-95. Epub 2007 Mar 26.

PMID:
17376687
48.

Breast conservation: current results and future perspectives at the European Institute of Oncology.

Veronesi U, Zurrida S.

Int J Cancer. 2007 Apr 1;120(7):1381-6. Review.

49.

Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study.

Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Maisonneuve P, Gatti G, Mazzarol G, De Cicco C, Manfredi G, Fernández JR.

Lancet Oncol. 2006 Dec;7(12):983-90.

PMID:
17138219
50.

Early detection of cancer: ideas for a debate.

Gennari R, Veronesi U, Andreoli C, Betka J, Castelli A, Gatti G, Hugosson J, Llovet JM, Melia J, Nakhosteen JA, Pastorino U, Sideri M, Stephan C, Veronesi P, Zurrida S.

Crit Rev Oncol Hematol. 2007 Feb;61(2):97-103. Epub 2006 Nov 20. Review.

PMID:
17113782

Supplemental Content

Loading ...
Support Center